In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer acquires Pharmacia in $59bn all stock deal

Executive Summary

Pfizer will buy Pharmacia in a tax-free stock-for-stock transaction worth $59bn. For each Pharmacia outstanding share, Pfizer will issue 1.4 shares of its own stock, worth $46.60 based on Pfizer's 10-day average market price--a 33% premium over Pharmacia's market average.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Partial Acquisition
    • Payment Includes Stock

Related Companies